{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:41:33Z","timestamp":1756993293551},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1369-8","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T07:30:54Z","timestamp":1431070254000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy"],"prefix":"10.1186","volume":"15","author":[{"given":"Bentao","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengyan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"issue":"6","key":"1369_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"R Zigeuner","year":"2013","unstructured":"Zigeuner R, Sylvester R, Burger M, Cowan N, B\u00f6hle A, Van Rhijn BW, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63(6):1059\u201371.","journal-title":"Eur Urol"},{"issue":"4","key":"1369_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1464-410X.1973.tb12175.x","volume":"45","author":"CB Williams","year":"1973","unstructured":"Williams CB, Mitchell JP. Carcinoma of the ureter\u2013a review of 54 cases. Br J Urol. 1973;45(4):377\u201387.","journal-title":"Br J Urol"},{"key":"1369_CR3","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","volume":"54","author":"CC Li","year":"2008","unstructured":"Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54:1127\u201334.","journal-title":"Eur Urol"},{"issue":"5","key":"1369_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.eururo.2012.02.042","volume":"61","author":"E Xylinas","year":"2012","unstructured":"Xylinas E, Rink M, Margulis V, Karakiewicz P, Novara G, Shariat SF, et al. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol. 2012;61(5):1069\u201370.","journal-title":"Eur Urol"},{"issue":"6","key":"1369_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","volume":"59","author":"M Babjuk","year":"2011","unstructured":"Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, B\u00f6hle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 2011;59(6):997\u20131008.","journal-title":"Eur Urol"},{"issue":"6","key":"1369_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224\u201333.","journal-title":"Cancer"},{"key":"1369_CR7","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/cncr.22970","volume":"110","author":"G Novara","year":"2007","unstructured":"Novara G, De MV, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 2007;110:1715.","journal-title":"Cancer"},{"key":"1369_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1464-410X.2011.10461.x","volume":"109","author":"B Milojevic","year":"2012","unstructured":"Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Bumbasirevic U, et al. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis. BJU Int. 2012;109:1037.","journal-title":"BJU Int"},{"key":"1369_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","volume":"48","author":"HG Van der Poel","year":"2005","unstructured":"Van der Poel HG, Antonini N, van Tinteren H, Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol. 2005;48:438\u201344.","journal-title":"Eur Urol"},{"issue":"11","key":"1369_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jfma.2013.11.004","volume":"113","author":"D Fang","year":"2014","unstructured":"Fang D, Xiong GY, Li XS, Chen XP, Zhang L, Yao L, et al. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience. J Formos Med Assoc. 2014;113(11):820\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"1369_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62(1):100\u201314.","journal-title":"Eur Urol"},{"key":"1369_CR12","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/onc.2011.403","volume":"31","author":"E Noetzel","year":"2012","unstructured":"Noetzel E, Rose M, Bornemann J, Gajewski M, Kn\u00fcchel R, Dahl E. Nuclear transport receptor karyopherin-alpha2 promotes malignant breast cancer phenotypes in vitro. Oncogene. 2012;31:2101\u201314.","journal-title":"Oncogene"},{"key":"1369_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1074\/mcp.M111.016592","volume":"11","author":"CI Wang","year":"2012","unstructured":"Wang CI, Chien KY, Wang CL, Liu HP, Cheng CC, Chang YS, et al. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer. Mol Cell Proteomics. 2012;11:1105\u201322.","journal-title":"Mol Cell Proteomics"},{"key":"1369_CR14","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/ijc.25568","volume":"128","author":"CI Wang","year":"2011","unstructured":"Wang CI, Wang CL, Wang CW, Chen CD, Wu CC, Liang Y, et al. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer. 2011;128:2364\u201372.","journal-title":"Int J Cancer"},{"key":"1369_CR15","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1158\/1078-0432.CCR-05-2090","volume":"12","author":"E Dahl","year":"2006","unstructured":"Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, et al. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res. 2006;12:3950\u201360.","journal-title":"Clin Cancer Res"},{"key":"1369_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/AOG.0b013e3181f104ce","volume":"116","author":"M Zheng","year":"2010","unstructured":"Zheng M, Tang L, Huang L, Ding H, Liao WT, Zeng MS, et al. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis. Obstet Gynecol. 2010;116:884\u201391.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1369_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/modpathol.2013.127","volume":"27","author":"K Grupp","year":"2014","unstructured":"Grupp K, Habermann M, Sirma H, Simon R, Steurer S, Hube-Magg C, et al. High nuclear karyopherin \u03b1 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Mod Pathol. 2014;27(1):96\u2013106.","journal-title":"Mod Pathol"},{"key":"1369_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.eururo.2011.01.048","volume":"59","author":"JB Jensen","year":"2011","unstructured":"Jensen JB, Munksgaard PP, Sorensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulh\u00f8i BP, et al. High expression of karyopherin-alpha2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy. Eur Urol. 2011;59:841\u20138.","journal-title":"Eur Urol"},{"issue":"2","key":"1369_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/ijc.28683","volume":"135","author":"C Webber","year":"2014","unstructured":"Webber C, Gospodarowicz M, Sobin LH, Wittekind C, Greene FL, Mason MD, et al. Improving the TNM classification: findings from a 10-year continuous literature review. Int J Cancer. 2014;135(2):371\u20138.","journal-title":"Int J Cancer"},{"key":"1369_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, B\u00e4rlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844\u20137.","journal-title":"Nat Med"},{"issue":"2","key":"1369_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/path.4390","volume":"234","author":"K Ikenberg","year":"2014","unstructured":"Ikenberg K, Valtcheva N, Brandt S, Zhong Q, Wong CE, Noske A, et al. KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. J Pathol. 2014;234(2):239\u201352.","journal-title":"J Pathol"},{"key":"1369_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1022945107762","volume":"8","author":"JD Ly","year":"2003","unstructured":"Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi (m)) in apoptosis; an update. Apoptosis. 2003;8:115\u201328.","journal-title":"Apoptosis"},{"key":"1369_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1073\/pnas.92.5.1769","volume":"92","author":"A Radu","year":"1995","unstructured":"Radu A, Blobel G, Moore MS. Identification of a protein complex that is required for nuclear protein import and mediates docking of import substrate to distinct nucleoporins. Proc Natl Acad Sci U S A. 1995;92:1769\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1369_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2004.07.016","volume":"14","author":"DS Goldfarb","year":"2004","unstructured":"Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 2004;14(9):505\u201314.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"1369_CR25","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1074\/jbc.R600026200","volume":"282","author":"A Lange","year":"2007","unstructured":"Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem. 2007;282(8):5101\u20135.","journal-title":"J Biol Chem"},{"key":"1369_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm2114","volume":"8","author":"M Stewart","year":"2007","unstructured":"Stewart M. Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol. 2007;8:195\u2013208.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1369_CR27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bju.12238","volume":"112","author":"XP Chen","year":"2013","unstructured":"Chen XP, Xiong GY, Li XS, Matin SF, Garcia M, Fang D, et al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from anationwide high-volume centre in China. BJU Int. 2013;112(7):917\u201324.","journal-title":"BJU Int"},{"key":"1369_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","volume":"98","author":"RE Zigeuner","year":"2006","unstructured":"Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006;98:1181\u20136.","journal-title":"BJU Int"},{"key":"1369_CR29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014;65:650\u20138.","journal-title":"Eur Urol"},{"key":"1369_CR30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.urolonc.2012.04.014","volume":"31","author":"KH Kim","year":"2013","unstructured":"Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1643\u20139.","journal-title":"Urol Oncol"},{"key":"1369_CR31","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/cncr.11691","volume":"98","author":"CH Kang","year":"2003","unstructured":"Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer. 2003;98:1620\u20136.","journal-title":"Cancer"},{"issue":"47","key":"1369_CR32","doi-asserted-by":"publisher","first-page":"39594","DOI":"10.1074\/jbc.M508425200","volume":"280","author":"SF Tseng","year":"2005","unstructured":"Tseng SF, Chang CY, Wu KJ, Teng SC. Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem. 2005;280(47):39594\u2013600.","journal-title":"J Biol Chem"},{"issue":"37","key":"1369_CR33","doi-asserted-by":"publisher","first-page":"32505","DOI":"10.1074\/jbc.M501449200","volume":"280","author":"YC Chen","year":"2005","unstructured":"Chen YC, Su YN, Chou PC, Chiang WC, Chang MC, Wang LS, et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase\/Akt. J Biol Chem. 2005;280(37):32505\u201311.","journal-title":"J Biol Chem"},{"key":"1369_CR34","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/tra.12097","volume":"14","author":"P Liang","year":"2013","unstructured":"Liang P, Zhang H, Wang G, Li S, Cong S, Luo Y, et al. KPNB1, XPO7 and IPO8 mediate the translocation of NF-kappaB\/p65 into the nucleus. Traffic. 2013;14:1132\u201343.","journal-title":"Traffic"},{"key":"1369_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1464-410X.2010.09210.x","volume":"106","author":"HC Yeh","year":"2010","unstructured":"Yeh HC, Huang CH, Yang SF, Li CC, Chang LL, Lin HH, et al. Nuclear factor-kappaB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma. BJU Int. 2010;106:1223\u20139.","journal-title":"BJU Int"},{"key":"1369_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.eururo.2012.11.050","volume":"65","author":"N Tanaka","year":"2014","unstructured":"Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, et al. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Eur Urol. 2014;65:227\u201334.","journal-title":"Eur Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1369-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1369-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T21:33:27Z","timestamp":1717882407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1369-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]},"assertion":[{"value":"3 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"380"}}